Over the past few decades, engineers have developed various devices that can create holograms, three-dimensional (3D) or ...

Data from ongoing Phase 1 study of AX-0810 in healthy volunteers demonstrated dose-dependent target engagement on all key biomarkers in the ...

Modern OCT devices can look inside the eye without a scalpel - but they do not always capture everything that matters. Some ...

Modern OCT devices can look inside the eye without a scalpel - but they do not always capture everything that matters. Some critical information is ...

Top line data readout expected in late Q3/early Q4; INFORM-MS trial is a randomized, double-blind, placebo-controlled Phase ...

A new approach for identifying signs of hidden awareness in people who cannot speak or move after severe brain injury has ...

Men diagnosed with metastatic prostate cancer that lacks the PTEN protein now have a targeted drug option for the first time.

Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced positive topline full study results from the Phase 3 VISIONARY trial. VOYXACT ® ...

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today provides shareholders a ...

Traditional SSVEP stimuli are essentially high‑contrast brightness modulations that strongly activate the occipital visual cortex, but they are ...

Trial is supported by Phase 2 results showing significant improvement in overall survival in women with newly diagnosed advanced ovarian cancer Novel immunotherapy technology demonstrating ...

The wAIHA market landscape is undergoing a significant evolution after years of dependence on broad immunosuppressive ...